kabutan

CellSource Co., Ltd.(4880) Summary

4880
TSE Standard
CellSource Co., Ltd.
366
JPY
-12
(-3.17%)
Apr 30, 10:12 am JST
2.28
USD
Apr 29, 9:12 pm EDT
Result
PTS
outside of trading hours
368.1
Apr 30, 10:12 am JST
Summary Chart Historical News Financial Result
PER
PBR
1.24
Yield
ー%
Margin Trading Ratio
27.13
Stock Price
Apr 30, 2026
Opening Apr 30, 9:00 am
373 JPY 2.32 USD
Previous Close Apr 28
378 JPY 2.37 USD
High Apr 30, 9:00 am
378 JPY 2.35 USD
Low Apr 30, 10:12 am
365 JPY 2.27 USD
Volume
24,400
Trading Value
9.00M JPY 0.06M USD
VWAP
368.9 JPY 2.3 USD
Minimum Trading Value
36,600 JPY 228 USD
Market Cap
7.26B JPY 0.05B USD
Number of Trades
39
Liquidity & Number of Trades
As of Apr 30, 2026
Liquidity
Mid
1-Year Average
175
1-Year High May 28, 2025
954
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 24, 2026 259,300 528,200 2.04
Apr 17, 2026 286,100 509,600 1.78
Apr 10, 2026 324,600 513,200 1.58
Apr 3, 2026 366,200 516,900 1.41
Mar 27, 2026 383,800 517,900 1.35
Company Profile
CellSource Co., Ltd. develops and sells regenerative medicine-related products and cosmetics, specializing in cell processing from fat and blood.
Sector
Pharmaceuticals
CellSource Co., Ltd. primarily focuses on regenerative medicine-related businesses, providing cell processing and storage services from blood and fat for medical institutions. The company operates facilities licensed for manufacturing specific cell products under the Act on the Safety of Regenerative Medicine, where they extract, culture, and cryopreserve adipose-derived stem cells. Additionally, CellSource offers consulting services for regulatory compliance and management support necessary for providing regenerative medicine, as well as sales of related medical equipment. Furthermore, the company manufactures and sells its own cosmetics brand "Signalift," which incorporates proprietary ingredients derived from adipose stem cell research. CellSource also supplies cosmetic raw materials and provides OEM manufacturing services.